Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial 3'RNA sequencing was performed in 1,733 ...

Lung adenocarcinoma remains one of the most challenging cancers to diagnose accurately, with pathologists spending countless hours examining tissue samples under microscopes to determine cancer grades ...

Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT) However, the prognostic value of the IMDC model for ICI-treated patients ...